Compounds > dihydroalprenolol
Page last updated: 2024-08-23

dihydroalprenolol and EHS Tumor

dihydroalprenolol has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delavier-Klutchko, C; Durieu-Trautmann, O; Hoebeke, J; Strosberg, AD1
Belousova, AK; Khabarov, SV; Solntseva, TI1

Other Studies

2 other study(ies) available for dihydroalprenolol and EHS Tumor

ArticleYear
Altered binding properties of beta-adrenergic receptors and lack of coupling to adenylate cyclase in P815 mastocytoma cells.
    European journal of pharmacology, 1985, Jan-22, Volume: 108, Issue:2

    Topics: Adenylyl Cyclases; Animals; Cell Line; Cell Membrane; Colforsin; Cyclic AMP; Dihydroalprenolol; Diterpenes; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Isoproterenol; Mast-Cell Sarcoma; Mice; Mice, Inbred DBA; Neoplasm Proteins; Receptors, Adrenergic, beta; Sarcoma, Experimental; Sodium Fluoride

1985
[Interaction of sarcolysine with beta-adrenoreceptors in tumor cells].
    Biokhimiia (Moscow, Russia), 1985, Volume: 50, Issue:11

    Topics: Adenylyl Cyclases; Animals; Binding Sites; Binding, Competitive; Dihydroalprenolol; In Vitro Techniques; Kinetics; Melphalan; Mice; Models, Biological; Propranolol; Receptors, Adrenergic, beta; Sarcoma 37; Sarcoma, Experimental

1985